🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 1, randomized, open label, 2 treatment, 2 period, 2-way cro...
Status
Completed
Location
Premiere Oncology
Start Date
2010-07
Trial ID
NCT01149720
Treatments Being Tested
The purpose of this study is to determine if tivantinib (ARQ 197) is effect...
Status
Completed
Location
Multiple Locations
Start Date
2012-12-27
Trial ID
NCT01755767
Treatments Being Tested
This study is to determine if the combination regimen of tivantinib with er...
Status
Terminated
Location
Multiple Locations
Start Date
2011-01-11
Trial ID
NCT01244191
Treatments Being Tested
The purpose of this study is to determine the effects of tivantinib on the ...
Status
Completed
Location
START - South Texas Accelerated Research Therapeutics, LLC
Start Date
2012-07
Trial ID
NCT01699061
Treatments Being Tested
This phase II trial studies the side effects and how well tivantinib works ...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2011-11
Trial ID
NCT01447914
This is a randomized, placebo-controlled, double blind phase 2 study design...
Status
Completed
Location
Multiple Locations
Start Date
2008-09
Trial ID
NCT00777309
This is an extension study that will allow participants to continue to rece...
Status
Completed
Location
Multiple Locations
Start Date
2010-08-31
Trial ID
NCT01178411
Treatments Being Tested
The purpose of this study is to determine the effects of tivantinib on the ...
Status
Completed
Location
START - South Texas Accelerated Research Therapeutics, LLC
Start Date
2011-12
Trial ID
NCT01517399
Treatments Being Tested
This randomized phase II trial studies how well tivantinib with or without ...
Status
Completed
Location
University of Arizona Cancer Center-Orange Grove Campus
Start Date
2012-08-20
Trial ID
NCT01688973
Treatments Being Tested